The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Case of Successful Radiofrequency Ablation of Multiple Bilateral Renal Cell Carcinomas in von Hippel-Lindau Disease

폰히펠린다우병 환자의 고주파 절제술

  • Moon, Sang Yi (Departments of Internal Medicine, College of Medicine, Dong-A University) ;
  • Kim, Dong Hyun (Departments of Internal Medicine, College of Medicine, Dong-A University) ;
  • Jung, Eui Han (Departments of Internal Medicine, College of Medicine, Dong-A University) ;
  • Park, So Young (Departments of Internal Medicine, College of Medicine, Dong-A University) ;
  • Park, Mi Kyung (Departments of Internal Medicine, College of Medicine, Dong-A University) ;
  • Kim, Duk Kyu (Departments of Internal Medicine, College of Medicine, Dong-A University) ;
  • Suh, Sunghwan (Departments of Internal Medicine, College of Medicine, Dong-A University)
  • 문상이 (동아대학교 의과대학 내과학교실) ;
  • 김동현 (동아대학교 의과대학 내과학교실) ;
  • 정의한 (동아대학교 의과대학 내과학교실) ;
  • 박소영 (동아대학교 의과대학 내과학교실) ;
  • 박미경 (동아대학교 의과대학 내과학교실) ;
  • 김덕규 (동아대학교 의과대학 내과학교실) ;
  • 서성환 (동아대학교 의과대학 내과학교실)
  • Received : 2013.10.19
  • Accepted : 2014.03.11
  • Published : 2014.11.01
⟨ Previous Next ⟩

Abstract

Von Hippel-Lindau (VHL) disease is an inherited, autosomal dominant syndrome that manifests as a variety of benign and malignant tumors in various organs. Notably, renal cell carcinoma (RCC) in patients with VHL disease tends to be multifocal and bilateral, and tends to recur or new tumors develop after removal. Radiofrequency ablation (RFA) has recently been introduced as a minimally invasive treatment for small hereditary RCCs with a low complication rate and a minimal decrease in renal function. We present a case of successful RFA of multiple bilateral RCCs in a 24-year-old female with VHL. Computed tomography (CT) of the abdomen revealed multiple bilateral RCCs. The patient received sequential RFA for the bilateral RCCs, resulting in a complete response. At the time of writing, there was no sign of recurrence or renal failure. In conclusion, percutaneous RFA is a promising treatment for VHL patients who cannot undergo surgery, with excellent treatment outcomes and minimal change in renal function.

폰히펠-린다우병의 신세포암의 표준치료는 콩팥 단위 보존 수술이지만 다발성, 양측성 및 재발을 잘한다는 특성으로 인해 여러 가지 한계가 존재하여, 최근에는 고주파 절제술을 통한 신세포암의 치료가 소개되고 있다. 저자들은 폰히펠-린다우병 환자가 다발성, 양측성 신세포암을 진단 후 순차적인 고주파 절제술을 통한 성공적인 치료의 1예를 문헌고찰과 함께 보고하고자 한다.

Keywords

References

  1. Maher ER, Yates JR, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990;77:1151-1163. https://doi.org/10.1093/qjmed/77.2.1151
  2. Park BK, Kim CK, Park SY, Shen SH. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes. Acta Radiol 2013;54:418-427. https://doi.org/10.1177/0284185113475441
  3. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinoma. AJR Am J Roentgenol 2007;189:429-436. https://doi.org/10.2214/AJR.07.2258
  4. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000;174:323-331. https://doi.org/10.2214/ajr.174.2.1740323
  5. Wolf JS Jr, Seifman BD, Montie JE. Nephron sparing surgery for suspected malignancy: open surgery compared to laparoscopy with selective use of hand assistance. J Urol 2000;163:1659-1664. https://doi.org/10.1016/S0022-5347(05)67515-5
  6. Bratslavsky G, Liu JJ, Johnson AD, et al. Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol 2008;179:67-70.
  7. Ploussard G, Droupy S, Ferlicot S, et al. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology 2007;70:435-439. https://doi.org/10.1016/j.urology.2007.04.040
  8. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008;179:75-79.
  9. Kim JH, Kim TH, Kim SD, Lee KS, Sung GT. Radiofrequency ablation of renal tumors: our experience. Korean J Urol 2011;52:531-537. https://doi.org/10.4111/kju.2011.52.8.531
  10. Pasticier G, Timsit MO, Badet L, et al. Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. Eur Urol 2006;49:485-490. https://doi.org/10.1016/j.eururo.2005.12.049